The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
The Analyst Verdict: Roivant Sciences In The Eyes Of 6 Experts
分析師的判決:6位專家眼中的Roivant Sciences
6 analysts have shared their evaluations of Roivant Sciences (NASDAQ:ROIV) during the recent three months, expressing a mix of bullish and bearish perspectives.
最近三個月來,有6位分析師分享了他們對Roivant Sciences(納斯達克股票代碼:ROIV)的評估,表達了看漲和看跌的觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估,說明了過去30天不斷變化的情緒,並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Roivant Sciences, revealing an average target of $18.33, a high estimate of $23.00, and a low estimate of $15.00. Observing a 12.8% increase, the current average has risen from the previous average price target of $16.25.
分析師爲Roivant Sciences設定了12個月的目標股價,顯示平均目標股價爲18.33美元,最高估計爲23.00美元,低估值爲15.00美元。目前的平均價格上漲了12.8%,已從之前的平均目標價16.25美元上漲。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級:一項詳盡的研究
A comprehensive examination of how financial experts perceive Roivant Sciences is...
對金融專家如何看待Ro...
登入免費觀看全文
登入/註冊